Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dried Blood Spot Testing | 2 | 2021 | 383 | 1.37 | Why? |
| Antibodies, Bacterial | 4 | 2019 | 510 | 0.86 | Why? |
| Cat-Scratch Disease | 1 | 2019 | 17 | 0.83 | Why? |
| Bartonella henselae | 1 | 2019 | 28 | 0.83 | Why? |
| Immunoglobulin G | 14 | 2021 | 21571 | 0.78 | Why? |
| Borrelia burgdorferi | 1 | 2018 | 31 | 0.76 | Why? |
| Antibodies, Viral | 21 | 2021 | 51949 | 0.73 | Why? |
| Immunoblotting | 1 | 2018 | 180 | 0.72 | Why? |
| Antibodies, Protozoan | 1 | 2018 | 121 | 0.71 | Why? |
| Toxoplasmosis | 1 | 2018 | 59 | 0.71 | Why? |
| Cryptococcus | 1 | 2017 | 29 | 0.70 | Why? |
| Serologic Tests | 6 | 2020 | 4359 | 0.68 | Why? |
| beta-Glucans | 1 | 2019 | 176 | 0.68 | Why? |
| Antigens, Fungal | 2 | 2018 | 106 | 0.67 | Why? |
| Pneumocystis carinii | 1 | 2019 | 205 | 0.67 | Why? |
| Lyme Disease | 1 | 2018 | 102 | 0.67 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.62 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.61 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.59 | Why? |
| Chromatography, Affinity | 1 | 2017 | 310 | 0.58 | Why? |
| Pneumonia, Pneumocystis | 1 | 2019 | 322 | 0.57 | Why? |
| Zika Virus | 2 | 2018 | 1924 | 0.56 | Why? |
| Immunoglobulin M | 6 | 2020 | 9091 | 0.55 | Why? |
| Mycoses | 2 | 2018 | 589 | 0.44 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.44 | Why? |
| Clinical Laboratory Techniques | 6 | 2020 | 23402 | 0.42 | Why? |
| Enzyme-Linked Immunosorbent Assay | 5 | 2021 | 7868 | 0.41 | Why? |
| Emigrants and Immigrants | 1 | 2018 | 888 | 0.38 | Why? |
| Minnesota | 2 | 2019 | 509 | 0.33 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.29 | Why? |
| United States Food and Drug Administration | 3 | 2021 | 1276 | 0.26 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.25 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.24 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.23 | Why? |
| Laboratory Proficiency Testing | 1 | 2021 | 85 | 0.21 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.21 | Why? |
| Encephalitis Virus, California | 1 | 2018 | 3 | 0.20 | Why? |
| Jews | 1 | 2021 | 117 | 0.19 | Why? |
| Encephalitis, California | 1 | 2018 | 12 | 0.19 | Why? |
| Phrenic Nerve | 1 | 2018 | 37 | 0.19 | Why? |
| Toxoplasma | 1 | 2018 | 61 | 0.18 | Why? |
| Rubella virus | 1 | 2018 | 46 | 0.18 | Why? |
| Culturally Competent Care | 1 | 2021 | 169 | 0.18 | Why? |
| Blastomycosis | 1 | 2017 | 8 | 0.18 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| Meningitis, Fungal | 1 | 2017 | 17 | 0.18 | Why? |
| Holidays | 1 | 2021 | 311 | 0.17 | Why? |
| Microarray Analysis | 1 | 2018 | 262 | 0.17 | Why? |
| Q Fever | 1 | 2018 | 130 | 0.16 | Why? |
| Rubella | 1 | 2018 | 127 | 0.16 | Why? |
| Meningitis | 1 | 2018 | 163 | 0.16 | Why? |
| Blood | 1 | 2017 | 274 | 0.15 | Why? |
| Peripheral Nervous System Diseases | 1 | 2018 | 193 | 0.15 | Why? |
| Meningoencephalitis | 1 | 2018 | 208 | 0.15 | Why? |
| Fluorescent Antibody Technique | 1 | 2018 | 835 | 0.15 | Why? |
| Cerebrospinal Fluid | 1 | 2017 | 234 | 0.15 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.15 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.15 | Why? |
| Humans | 38 | 2021 | 930598 | 0.15 | Why? |
| Diaphragm | 1 | 2018 | 232 | 0.15 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.14 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.14 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.13 | Why? |
| Brucella | 1 | 2012 | 14 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.12 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| United States | 10 | 2021 | 46150 | 0.12 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.12 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.12 | Why? |
| Brucellosis | 1 | 2012 | 49 | 0.12 | Why? |
| Agglutination Tests | 1 | 2012 | 124 | 0.12 | Why? |
| Cytomegalovirus Infections | 1 | 2018 | 667 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.11 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.11 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.10 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.10 | Why? |
| Immunoenzyme Techniques | 1 | 2012 | 448 | 0.10 | Why? |
| Female | 18 | 2021 | 380317 | 0.10 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.10 | Why? |
| Adult | 13 | 2021 | 244371 | 0.10 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Aged | 10 | 2021 | 215776 | 0.09 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.09 | Why? |
| Disease Transmission, Infectious | 2 | 2021 | 9044 | 0.09 | Why? |
| Guillain-Barre Syndrome | 1 | 2020 | 1495 | 0.08 | Why? |
| Seasons | 1 | 2019 | 4071 | 0.08 | Why? |
| Pregnancy | 3 | 2018 | 23879 | 0.08 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.08 | Why? |
| Male | 12 | 2021 | 367725 | 0.08 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.07 | Why? |
| Seroepidemiologic Studies | 4 | 2021 | 10017 | 0.07 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.07 | Why? |
| Germany | 1 | 2020 | 9196 | 0.07 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.07 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| Judaism | 1 | 2021 | 45 | 0.05 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Antigenic Variation | 1 | 2021 | 249 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| Pathologists | 1 | 2021 | 168 | 0.05 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Connecticut | 1 | 2021 | 547 | 0.05 | Why? |
| Green Fluorescent Proteins | 1 | 2020 | 450 | 0.05 | Why? |
| New Jersey | 1 | 2021 | 528 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.05 | Why? |
| Blastomyces | 1 | 2017 | 6 | 0.04 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Coxiella burnetii | 1 | 2018 | 120 | 0.04 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.04 | Why? |
| Cryptococcus neoformans | 1 | 2018 | 71 | 0.04 | Why? |
| Soft Tissue Infections | 1 | 2018 | 116 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| Societies, Scientific | 1 | 2018 | 414 | 0.04 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.03 | Why? |
| Fungi | 1 | 2018 | 471 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| California | 1 | 2021 | 2047 | 0.03 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Child | 3 | 2018 | 70012 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.03 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.03 | Why? |
| Brain | 2 | 2018 | 5133 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2021 | 3088 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2018 | 2149 | 0.02 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Diagnostic Errors | 1 | 2012 | 865 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.02 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.01 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.00 | Why? |
Theel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(210)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_